Tempus AI, Inc.

Public Equity (NASDAQ)AIHealthcarePublic

📍 Chicago, IL, United States• Founded 2015

StreetZero Signal 69

Be the first to signal interest

About Tempus AI, Inc.

Tempus AI, Inc. is a precision medicine technology company that uses artificial intelligence to analyze clinical and molecular data, primarily in oncology. It aggregates multimodal datasets from healthcare providers and research institutions to support personalized treatment decisions and drug development. The company went public via NASDAQ under the ticker TEM.

LATEST FUNDINGRule 144

$16.8M

Announced 2026-10-27

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Tempus AI, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES—

FOUNDED2015

HQChicago, IL, United States

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Completed a $16.79M Rule 144 private placement of public equity.
Focuses on AI-driven precision medicine using large-scale clinical and molecular datasets.
Headquartered in Chicago with NASDAQ listing under TEM.

Ask StreetZero about Tempus AI, Inc.

Put our AI to work on this deal.

What is Tempus AI, Inc.'s value proposition?Who are Tempus AI, Inc.'s competitors?Why does this raise matter?Summarize Tempus AI, Inc. for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Crowdstrike Holdings, Inc.

$141.0M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.